Last reviewed · How we verify
NCT06683430
High Potassium Diet with Spices and Herbs As Salt Substitute for Lowering Blood Pressure in Older Adults: Study Protocol
NA trial testing High Potassium, Low Sodium Diet in Hypertension in 62 participants. Completed in 9 February 2024.
30 June 2023
Quick facts
| Lead sponsor | Universitas Airlangga |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 62 |
| Start date | 11 May 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 9 February 2024 |
| Sites | 1 location across Angola |
Drugs / interventions tested
- High Potassium, Low Sodium Diet
- Standard Diet — full drug profile →
Conditions studied
- Hypertension — all drugs for Hypertension →
- Older Adults Institutionalized in Residential Homes — all drugs for Older Adults Institutionalized in Residential Homes →
Sponsor
Universitas Airlangga — full company profile →
Who can join
60 and older, any sex, with Hypertension or Older Adults Institutionalized in Residential Homes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial aims to evaluate the High Potassium Diet Rich in Spices and Herbs-Salt Substitution (HPSH-SS) for reducing blood pressure in older adults. The study has two phases: the first focuses on developing a high-potassium, low-sodium diet, while the second involves a 14-day randomized controlled trial. Participants are divided into two groups: the intervention group (IG) receives an 1800 kcal daily diet with 3500 mg potassium and 1500 mg sodium, while the control group (CG) receives a diet with 1500 mg potassium and 2000 mg sodium. Key outcomes include changes in blood pressure, serum potassium, aldosterone, nitric oxide, and oxidative stress markers. The results could provide new dietary strategies for managing blood pressure in the elderly.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06683430
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Universitas Airlangga trials
Trials by the same sponsor.
- NCT07418762 — Community-Based Program Integrating Nurse-Led Mind-Body Exercise and Nutrition for Frailty · NA · not yet recruiting
- NCT07265856 — The Effect of a Comprehensive Dementia Education Program on Improving Attitudes Toward People Living With Dementia · NA · enrolling by invitation
- NCT07238439 — Scenario-Driven Virtual Reality Game for Dementia Education Program · NA · enrolling by invitation
- NCT06629844 — Enhancing Healthcare Students' Attitudes Toward Dementia Care Through Virtual Reality Education · NA · completed
- NCT06160765 — The Efficacy of High Density Formula 1.5 kcal/ml or 1 kcal/ml On Catch Up Growth In Growth Faltering Children · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06683430 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitas Airlangga
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06683430.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing